Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Health Technology Assessment and Its Use in Drug Policy in Malaysia.

Shafie AA, Chandriah H, Yong YV, Wan Puteh SE.

Value Health Reg Issues. 2019 May;18:145-150. doi: 10.1016/j.vhri.2019.03.003. Epub 2019 May 10.

PMID:
31082794
2.

Consensus among healthcare stakeholders on a collaborative medication therapy management model for chronic diseases in Malaysia; A Delphi study.

Mubarak N, Hatah E, Aris MAM, Shafie AA, Zin CS.

PLoS One. 2019 May 10;14(5):e0216563. doi: 10.1371/journal.pone.0216563. eCollection 2019.

3.

Estimating the utility value of hypoglycaemia according to severity and frequency using the visual analogue scale (VAS) and time trade-off (TTO) survey.

Shafie AA, Ng CH, Thanimalai S, Haron N, Manocha AB.

J Diabetes Metab Disord. 2018 Nov 7;17(2):269-275. doi: 10.1007/s40200-018-0369-z. eCollection 2018 Dec.

4.

Valuation of EQ-5D-5L health states: a comparison of seven Asian populations.

Wang P, Liu GG, Jo MW, Purba FD, Yang Z, Gandhi M, Pattanaphesaj J, Ahn J, Wong EL, Shafie AA, Busschbach JJ, Luo N.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec 7. doi: 10.1080/14737167.2019.1557048. [Epub ahead of print]

PMID:
30523723
5.

EQ-5D-5L Valuation for the Malaysian Population.

Shafie AA, Vasan Thakumar A, Lim CJ, Luo N, Rand-Hendriksen K, Md Yusof FA.

Pharmacoeconomics. 2019 May;37(5):715-725. doi: 10.1007/s40273-018-0758-7.

PMID:
30535779
6.

The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study.

Yeo HY, Shafie AA.

Cost Eff Resour Alloc. 2018 Nov 22;16:60. doi: 10.1186/s12962-018-0163-2. eCollection 2018.

7.

Using a dynamic adherence Markov model to assess the efficiency of Respiratory Medication Therapy Adherence Clinic (RMTAC) on asthma patients in Malaysia.

Yong YV, Shafie AA.

Cost Eff Resour Alloc. 2018 Oct 19;16:36. doi: 10.1186/s12962-018-0156-1. eCollection 2018.

8.

Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.

Shafie AA, Vasan Thakumar A, Lim CJ, Luo N.

Qual Life Res. 2019 Jan;28(1):153-162. doi: 10.1007/s11136-018-2027-9. Epub 2018 Oct 13.

PMID:
30317426
9.

HISTORICAL DEVELOPMENT OF THE HTAsiaLINK NETWORK AND ITS KEY DETERMINANTS OF SUCCESS.

Teerawattananon Y, Luz K, Yothasmutra C, Pwu RF, Ahn J, Shafie AA, Chalkidou K, Tantivess S, Santatiwongchai B, Rattanavipapong W, Dabak S.

Int J Technol Assess Health Care. 2018 Jan;34(3):260-266. doi: 10.1017/S0266462318000223. Epub 2018 Jun 18.

PMID:
29911515
10.

Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: A meta-analysis of randomized controlled trials in cesarean deliveries.

Voon HY, Suharjono HN, Shafie AA, Bujang MA.

Taiwan J Obstet Gynecol. 2018 Jun;57(3):332-339. doi: 10.1016/j.tjog.2018.04.002.

11.

Scholarly publishing depends on peer reviewers.

Fernandez-Llimos F; Pharmacy Practice 2017 peer reviewers.

Pharm Pract (Granada). 2018 Jan-Mar;16(1):1236. doi: 10.18549/PharmPract.2018.01.1236. Epub 2018 Mar 27.

12.

Relationship between self-efficacy, self-care behaviour and glycaemic control among patients with type 2 diabetes mellitus in the Malaysian primary care setting.

Tharek Z, Ramli AS, Whitford DL, Ismail Z, Mohd Zulkifli M, Ahmad Sharoni SK, Shafie AA, Jayaraman T.

BMC Fam Pract. 2018 Mar 9;19(1):39. doi: 10.1186/s12875-018-0725-6.

13.

How Much Does Management of an Asthma-Related Event Cost in a Malaysian Suburban Hospital?

Yong YV, Shafie AA.

Value Health Reg Issues. 2018 May;15:6-11. doi: 10.1016/j.vhri.2017.05.001. Epub 2017 Jun 21.

PMID:
29474180
14.

Cost-Effectiveness of Warfarin Medication Therapy Adherence Clinic versus Usual Medical Clinic at Kuala Lumpur Hospital.

Thanimalai S, Shafie AA, Ahmad Hassali MA, Sinnadurai J.

Value Health Reg Issues. 2018 May;15:34-41. doi: 10.1016/j.vhri.2017.05.006. Epub 2017 Jul 17.

PMID:
29474176
15.

ISPOR Code of Ethics 2017 (4th Edition).

Santos J, Palumbo F, Molsen-David E, Willke RJ, Binder L, Drummond M, Ho A, Marder WD, Parmenter L, Sandhu G, Shafie AA, Thompson D.

Value Health. 2017 Dec;20(10):1227-1242. doi: 10.1016/j.jval.2017.10.018. Epub 2017 Dec 6.

16.

Systematic review of economic burden of heart failure.

Shafie AA, Tan YP, Ng CH.

Heart Fail Rev. 2018 Jan;23(1):131-145. doi: 10.1007/s10741-017-9661-0.

PMID:
29124528
17.

Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit.

Voon HY, Shafie AA, Bujang MA, Suharjono HN.

J Obstet Gynaecol Res. 2018 Jan;44(1):109-116. doi: 10.1111/jog.13486. Epub 2017 Oct 13.

18.

Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.

Lim YW, Shafie AA, Chua GN, Ahmad Hassali MA.

Value Health. 2017 Sep;20(8):1131-1138. doi: 10.1016/j.jval.2017.04.002. Epub 2017 Jun 2.

19.

Assessment of medication adherence and the costs associated with a calendar blister pack intervention among hypertensive patients in Malaysia: A randomized controlled trial.

Tan BY, Shafie AA, Hassali MAA, Saleem F.

SAGE Open Med. 2017 Aug 3;5:2050312117709189. doi: 10.1177/2050312117709189. eCollection 2017.

20.

Response to Linguistic and psychometric validation of the Malaysian version of Diabetes Quality of Life-Brief Clinical Inventory (DQoL-BCI): Methodological issues to avoid misinterpretation.

Neoh CF, Samah S, Wong YY, Hassali MA, Shafie AA, Lim SM, Ramasamy K, Mat Nasir N, Han YW, Burroughs T.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):884. doi: 10.1016/j.sapharm.2017.02.004. Epub 2017 Feb 12. No abstract available.

PMID:
28259586
21.

The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling.

Shafie AA, Yeo HY, Coudeville L, Steinberg L, Gill BS, Jahis R, Amar-Singh Hss.

Pharmacoeconomics. 2017 May;35(5):575-589. doi: 10.1007/s40273-017-0487-3.

PMID:
28205150
22.

Effectiveness of the EMPOWER-PAR Intervention in Improving Clinical Outcomes of Type 2 Diabetes Mellitus in Primary Care: A Pragmatic Cluster Randomised Controlled Trial.

Ramli AS, Selvarajah S, Daud MH, Haniff J, Abdul-Razak S, Tg-Abu-Bakar-Sidik TM, Bujang MA, Chew BH, Rahman T, Tong SF, Shafie AA, Lee VK, Ng KK, Ariffin F, Abdul-Hamid H, Mazapuspavina MY, Mat-Nasir N, Chan CW, Yong-Rafidah AR, Ismail M, Lakshmanan S, Low WH; EMPOWER-PAR Investigators.

BMC Fam Pract. 2016 Nov 14;17(1):157.

23.

Linguistic and psychometric validation of the Malaysian version of Diabetes Quality of Life-Brief Clinical Inventory (DQoL-BCI).

Samah S, Neoh CF, Wong YY, Hassali MA, Shafie AA, Lim SM, Ramasamy K, Mat Nasir N, Han YW, Burroughs T.

Res Social Adm Pharm. 2017 Nov;13(6):1135-1141. doi: 10.1016/j.sapharm.2016.10.017. Epub 2016 Oct 24.

PMID:
27825607
24.

Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.

Shafie AA, Ng CH, Tan YP, Chaiyakunapruk N.

Pharmacoeconomics. 2017 Feb;35(2):141-162. doi: 10.1007/s40273-016-0456-2. Review.

PMID:
27752998
25.

State of rare disease management in Southeast Asia.

Shafie AA, Chaiyakunapruk N, Supian A, Lim J, Zafra M, Hassali MA.

Orphanet J Rare Dis. 2016 Aug 2;11(1):107. doi: 10.1186/s13023-016-0460-9.

26.

Knowledge, attitudes, and quality of life of type 2 diabetes patients in Riyadh, Saudi Arabia.

Al-Aboudi IS, Hassali MA, Shafie AA.

J Pharm Bioallied Sci. 2016 Jul-Sep;8(3):195-202. doi: 10.4103/0975-7406.171683.

27.
28.

A cross-sectional assessment of health-related quality of life among type 2 diabetes patients in Riyadh, Saudi Arabia.

Al-Aboudi IS, Hassali MA, Shafie AA, Hassan A, Alrasheedy AA.

SAGE Open Med. 2015 Oct 9;3:2050312115610129. doi: 10.1177/2050312115610129. eCollection 2015.

29.

The need to incorporate generic medicines topic in the curriculum of Yemeni pharmacy colleges.

Al-Tamimi SK, Hassali MA, Shafie AA, ALrasheedy AA.

Int J Pharm Pract. 2016 Feb;24(1):72-3. doi: 10.1111/ijpp.12204. No abstract available.

PMID:
26764227
30.

Association Among Calendar Packaging And Medication Adherence: Findings From A Focus Group Discussion Among Hypertensive Patients In Penang, Malaysia.

Tan BY, Shafie AA, Hassali MA, Saleem F, Kumar R.

Value Health. 2015 Nov;18(7):A831. doi: 10.1016/j.jval.2015.09.317. Epub 2015 Oct 20. No abstract available.

31.

Developing and Validating a New Tool: Physicians' Barriers, Attitudes and Practices Towards Applying Smoking Cessation Interventions in Their Clinics.

Albaroodi KA, Syed Sulaiman SA, Awaisu A, Shafie AA, Lajis R, Abo-Maali MF.

Value Health. 2015 Nov;18(7):A714. doi: 10.1016/j.jval.2015.09.2692. Epub 2015 Oct 20. No abstract available.

32.

Potential Health And Economic Impact Of Introducing A Dengue Vaccine In Malaysia: Assessment Using Dynamic Transmission Modelling.

Yeo HY, Shafie AA, Coudeville L, Steinberg LD, Gill BS, Jahis R.

Value Health. 2015 Nov;18(7):A582. doi: 10.1016/j.jval.2015.09.1949. Epub 2015 Oct 20. No abstract available.

33.

Economic Evaluation Of Respiratory Medication Therapy Adherence Clinic (Rmtac) On Asthma Patients In Malaysia.

Yong YV, Shafie AA.

Value Health. 2015 Nov;18(7):A501. doi: 10.1016/j.jval.2015.09.1419. Epub 2015 Oct 20. No abstract available.

34.

Development, test-retest reliability and validity of the Pharmacy Value-Added Services Questionnaire (PVASQ).

Tan CL, Hassali MA, Saleem F, Shafie AA, Aljadhey H, Gan VB.

Pharm Pract (Granada). 2015 Apr-Jun;13(3):598. doi: 10.18549/PharmPract.2015.03.598. Epub 2015 Jun 15.

35.

Building intentions with the theory of planned behaviour: a qualitative assessment of salient beliefs about pharmacy value added services in Malaysia.

Tan CL, Hassali MA, Saleem F, Shafie AA, Aljadhay H, Gan VB.

Health Expect. 2016 Dec;19(6):1215-1225. doi: 10.1111/hex.12416. Epub 2015 Oct 1.

36.

Understanding and perceptions of final-year Doctor of Pharmacy students about generic medicines in Karachi, Pakistan: a quantitative insight.

Jamshed SQ, Ibrahim MI, Hassali MA, Sharrad AK, Shafie AA, Babar ZU.

Adv Med Educ Pract. 2015 May 15;6:359-66. doi: 10.2147/AMEP.S27762. eCollection 2015.

37.

Duration of treatment in pulmonary tuberculosis: are international guidelines on the management of tuberculosis missing something?

Atif M, Sulaiman SA, Shafie AA, Babar ZU.

Public Health. 2015 Jun;129(6):777-82. doi: 10.1016/j.puhe.2015.04.010. Epub 2015 May 18.

PMID:
25999175
38.

Assessment of knowledge, attitude and practice of food allergies among food handlers in the state of Penang, Malaysia.

Shafie AA, Azman AW.

Public Health. 2015 Sep;129(9):1278-84. doi: 10.1016/j.puhe.2015.03.016. Epub 2015 Apr 28.

PMID:
25931434
39.

Economic evaluation of enhanced asthma management: a systematic review.

Yong YV, Shafie AA.

Pharm Pract (Granada). 2014 Oct;12(4):493. Epub 2014 Mar 15.

40.

An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes.

Gupta V, Baabbad R, Hammerby E, Nikolajsen A, Shafie AA.

J Med Econ. 2015 Apr;18(4):263-72. doi: 10.3111/13696998.2014.991791. Epub 2015 Jan 2.

PMID:
25426701
41.

Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.

Shafie AA, Lim YW, Chua GN, Hassali MA.

Clinicoecon Outcomes Res. 2014 Oct 23;6:473-81. doi: 10.2147/CEOR.S67375. eCollection 2014.

42.

Effect of Health Education Program on Knowledge, Attitude, Practice and Health Related Quality of Life in Hepatitis-B Patients.

Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Iqbal Q.

Value Health. 2014 Nov;17(7):A807. doi: 10.1016/j.jval.2014.08.529. Epub 2014 Oct 26. No abstract available.

43.

Duration of Treatment in Pulmonary Tuberculosis: are International Guidelines on the Management of Tuberculosis Missing Something?

Atif M, Sulaiman SA, Shafie AA, Asif M.

Value Health. 2014 Nov;17(7):A780. doi: 10.1016/j.jval.2014.08.372. Epub 2014 Oct 26. No abstract available.

44.

Missing data Analysis in Longitudinal Studies: Findings from a Quality of Life Study in Malaysian Tuberculosis Patients.

Atif M, Toghrayee Z, Sulaiman SA, Shafie AA, Low HC, Babar ZU.

Value Health. 2014 Nov;17(7):A778. doi: 10.1016/j.jval.2014.08.361. Epub 2014 Oct 26. No abstract available.

45.

Prevalence and Predictors of Clinically Undiagnosed Cognitive Impairment Among Older Residents of Nursing Homes in Association with HRQOL.

Chen LL, Ch'ng SH, Shafie AA, Hasali MA, Tagiisuran B.

Value Health. 2014 Nov;17(7):A770. doi: 10.1016/j.jval.2014.08.310. Epub 2014 Oct 26. No abstract available.

46.

Resource Utilization Pattern And Cost Of Tuberculosis Treatment In Penang, Malaysia.

Atif M, Sulaiman SA, Shafie AA, Asif M.

Value Health. 2014 Nov;17(7):A725-6. doi: 10.1016/j.jval.2014.08.051. Epub 2014 Oct 26. No abstract available.

47.

The Prevalence of Tobacco Smoking in Patients With Diabetes in Hospital Pulau Pinang, Malaysia.

Albaroodi KA, Syed Sulaiman SA, Shafie AA, Awaisu A, Lajis R.

Value Health. 2014 Nov;17(7):A590. doi: 10.1016/j.jval.2014.08.2023. Epub 2014 Oct 26. No abstract available.

48.

The Measurement Of Utilities In Asthma Patients: A Preliminary Study.

Yong YV, Shafie AA.

Value Health. 2014 Nov;17(7):A568. doi: 10.1016/j.jval.2014.08.1892. Epub 2014 Oct 26. No abstract available.

49.

Assessing The Cost Effectiveness Of An Anticoagulation Clinic In Comparison With The Usual Medical Clinic In Kuala Lumpur Hospital.

Thanimalai S, Shafie AA, Ahmad HM, Sinnadurai J.

Value Health. 2014 Nov;17(7):A487. doi: 10.1016/j.jval.2014.08.1428. Epub 2014 Oct 26. No abstract available.

50.

Determination of Cost-Effectiveness Threshold For Malaysia.

Lim YW, Shafie AA, Chua GN, Hassali MA.

Value Health. 2014 Nov;17(7):A438. doi: 10.1016/j.jval.2014.08.1137. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Loading ...
Support Center